LASA SUPERGENERICS
Back to Balance Sheet
|
LASA SUPERGENERICS Last 5 Year Deferred Tax Assets / Liabilities History
[Standalone]
| Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹4.85 Cr | ₹2.24 Cr | ₹5.91 Cr | ₹7.82 Cr | ₹-3.17 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of LASA SUPERGENERICS ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2024 | ₹4.85 Cr |
| Mar2023 | ₹2.24 Cr |
| Mar2022 | ₹5.91 Cr |
| Mar2021 | ₹7.82 Cr |
| Mar2020 | ₹-3.17 Cr |
How is Deferred Tax Assets / Liabilities of LASA SUPERGENERICS Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2024 | ₹4.85 Cr | 116.91 | |
| Mar2023 | ₹2.24 Cr | -62.20 | |
| Mar2022 | ₹5.91 Cr | -24.42 | |
| Mar2021 | ₹7.82 Cr | Positive | |
| Mar2020 | ₹-3.17 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of LASA SUPERGENERICS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LASA SUPERGENERICS | ₹60.6 Cr | 1.5% | 20% | -58.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹422,631.0 Cr | 1.9% | -0.8% | -3.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹175,111.0 Cr | 3.2% | 4.8% | 12.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹136,228.0 Cr | 6.3% | 8.9% | 15.8% | Stock Analytics | |
| CIPLA | ₹117,983.0 Cr | -3.3% | -2% | -1.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,782.0 Cr | -3.8% | -3.1% | -8% | Stock Analytics | |
LASA SUPERGENERICS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LASA SUPERGENERICS | 1.5% |
20% |
-58.3% |
| SENSEX | -1.2% |
-1.1% |
6.3% |
You may also like the below Video Courses